Genprex

GNPX

GNPX Genprex NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    GNPX Chart
    See on advanced chart >

    About

    Genprex, Inc. was incorporated in Delaware in April 2009. The company is a privately held, clinical-stage biopharmaceutical company developing immunogene therapies for cancer. Genprex is a clinical stage gene therapy company developing a new approach to...
    • Highlight
      A biotechnology company that develops and commercializes novel gene therapies for cancer and diabetes
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      03/29/2018
    • Established Date
      Invalid Date
    • Full-time Employees
      26
    • Address
      3300 Bee Cave Road #650-227 Austin Texas 78746
    • Tel
      1-512-5377997
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock